Shenzhen New Industries Biomedical Engineering Co., Ltd. logo

Shenzhen New Industries Biomedical Engineering Co., Ltd.

300832.SZ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
635
Cost of Revenue
177
Gross Profit
458
Gross Margin
72.1%
Operating Income
296
Operating Margin
46.5%
Net Income
256
Net Margin
40.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
295
EBITDA Margin
46.5%

2023

12/31/2023

Revenue
550
Cost of Revenue
149
Gross Profit
401
Gross Margin
72.9%
Operating Income
265
Operating Margin
48.2%
Net Income
232
Net Margin
42.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
264
EBITDA Margin
48.0%

2022

12/31/2022

Revenue
427
Cost of Revenue
127
Gross Profit
300
Gross Margin
70.3%
Operating Income
211
Operating Margin
49.3%
Net Income
186
Net Margin
43.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
202
EBITDA Margin
47.4%

2021

12/31/2021

Revenue
356
Cost of Revenue
103
Gross Profit
254
Gross Margin
71.2%
Operating Income
159
Operating Margin
44.7%
Net Income
136
Net Margin
38.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
161
EBITDA Margin
45.2%

2020

12/31/2020

Revenue
307
Cost of Revenue
70
Gross Profit
237
Gross Margin
77.2%
Operating Income
154
Operating Margin
50.0%
Net Income
131
Net Margin
42.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
154
EBITDA Margin
50.2%